Dorothe Ankel‐Fuchs

1.1k total citations
21 papers, 834 citations indexed

About

Dorothe Ankel‐Fuchs is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Dorothe Ankel‐Fuchs has authored 21 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Dorothe Ankel‐Fuchs's work include Porphyrin Metabolism and Disorders (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Urinary Tract Infections Management (3 papers). Dorothe Ankel‐Fuchs is often cited by papers focused on Porphyrin Metabolism and Disorders (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Urinary Tract Infections Management (3 papers). Dorothe Ankel‐Fuchs collaborates with scholars based in Germany, Netherlands and United Kingdom. Dorothe Ankel‐Fuchs's co-authors include Rudolf K. Thauer, Lothar Heinisch, Ute Möllmann, A. Bauernfeind, Thilo Köhler, Simon P. J. Albracht, Johanna Moll, Rolf Jaenchen, J.W. van der Zwaan and Andreas Pfaltz and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Journal of Bacteriology.

In The Last Decade

Dorothe Ankel‐Fuchs

21 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothe Ankel‐Fuchs Germany 15 461 163 123 108 108 21 834
Maria J. Feio Portugal 16 650 1.4× 69 0.4× 90 0.7× 72 0.7× 84 0.8× 24 1.2k
Aaron W. Puri United States 17 1.0k 2.2× 29 0.2× 111 0.9× 55 0.5× 55 0.5× 28 1.3k
A Böck Germany 20 1.0k 2.2× 34 0.2× 304 2.5× 21 0.2× 48 0.4× 26 1.6k
Karine Bagramyan Armenia 20 759 1.6× 40 0.2× 327 2.7× 17 0.2× 12 0.1× 32 1.5k
Stefan Siemann Canada 14 230 0.5× 206 1.3× 58 0.5× 81 0.8× 41 0.4× 36 725
Athanasios Paschos Canada 16 409 0.9× 66 0.4× 559 4.5× 9 0.1× 87 0.8× 27 1.1k
Alexandra Gennaris Belgium 5 412 0.9× 58 0.4× 75 0.6× 23 0.2× 32 0.3× 6 937
Jürgen Moser Germany 22 1.0k 2.3× 58 0.4× 253 2.1× 40 0.4× 137 1.3× 48 1.4k
Yu Zeng China 21 491 1.1× 354 2.2× 84 0.7× 82 0.8× 42 0.4× 57 1.3k
Endang Purwantini United States 14 365 0.8× 25 0.2× 27 0.2× 33 0.3× 21 0.2× 25 548

Countries citing papers authored by Dorothe Ankel‐Fuchs

Since Specialization
Citations

This map shows the geographic impact of Dorothe Ankel‐Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothe Ankel‐Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothe Ankel‐Fuchs more than expected).

Fields of papers citing papers by Dorothe Ankel‐Fuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothe Ankel‐Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothe Ankel‐Fuchs. The network helps show where Dorothe Ankel‐Fuchs may publish in the future.

Co-authorship network of co-authors of Dorothe Ankel‐Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothe Ankel‐Fuchs. A scholar is included among the top collaborators of Dorothe Ankel‐Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothe Ankel‐Fuchs. Dorothe Ankel‐Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Möllmann, Ute, et al.. (2011). 8-Acyloxy-1,3-benzoxazine-2,4-diones as Siderophore Components for Antibiotics. Arzneimittelforschung. 50(8). 752–757. 2 indexed citations
3.
Möllmann, Ute, Lothar Heinisch, A. Bauernfeind, Thilo Köhler, & Dorothe Ankel‐Fuchs. (2009). Siderophores as drug delivery agents: application of the “Trojan Horse” strategy. BioMetals. 22(4). 615–624. 217 indexed citations
4.
Naber, Kurt G., I. James, H. Schneider, et al.. (2004). Gatifloxacin 400mg as a single shot or 200mg once daily for 3 days is as effective as ciprofloxacin 250mg twice daily for the treatment of patients with uncomplicated urinary tract infections. International Journal of Antimicrobial Agents. 23(6). 596–605. 28 indexed citations
5.
Kinzig‐Schippers, Martina, et al.. (2004). Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose. International Journal of Antimicrobial Agents. 23. 6–16. 32 indexed citations
6.
7.
Heinisch, Lothar, et al.. (2003). Catecholates and mixed catecholate hydroxamates as artificial siderophores for mycobacteria. BioMetals. 17(1). 53–64. 10 indexed citations
8.
Ankel‐Fuchs, Dorothe, et al.. (2000). ChemInform Abstract: 8‐Acyloxy‐1,3‐benzoxazine‐2,4‐diones as Siderophore Components for Antibiotics.. ChemInform. 31(46). 9 indexed citations
9.
Cheesman, Myles R., et al.. (1989). The magnetic properties of the nickel cofactor F430 in the enzyme methyl-coenzyme M reductase of Methanobacterium thermoautotrophicum. Biochemical Journal. 260(2). 613–616. 20 indexed citations
10.
Albracht, Simon P. J., Dorothe Ankel‐Fuchs, R. Böcher, et al.. (1988). Five new EPR signals assigned to nickel in methyl-coenzyme M reductase from Methanobacterium thermoautotrophicum, strain Marburg. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 955(1). 86–102. 71 indexed citations
11.
Bokranz, Martin, et al.. (1988). Cloning and characterization of the methyl coenzyme M reductase genes from Methanobacterium thermoautotrophicum. Journal of Bacteriology. 170(2). 568–577. 63 indexed citations
12.
Ankel‐Fuchs, Dorothe, R. Böcher, Rudolf K. Thauer, K M Noll, & R. S. Wolfe. (1987). 7‐Mercaptoheptanoylthreonine phosphate functions as component B in ATP‐independent methane formation from methyl‐CoM with reduced cobalamin as electron donor. FEBS Letters. 213(1). 123–127. 14 indexed citations
13.
14.
Ankel‐Fuchs, Dorothe, et al.. (1986). Structure and function of methyl-coenzyme M reductase and of factor F430 in methanogenic bacteria. Systematic and Applied Microbiology. 7(2-3). 383–387. 30 indexed citations
15.
Albracht, Simon P. J., Dorothe Ankel‐Fuchs, J.W. van der Zwaan, Ruud D. Fontijn, & Rudolf K. Thauer. (1986). A new EPR signal of nickel in Methanobacterium thermoautotrophicum. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 870(1). 50–57. 37 indexed citations
16.
Ankel‐Fuchs, Dorothe & Rudolf K. Thauer. (1986). Methane formation from methyl-coenzyme M in a system containing methyl-coenzyme M reductase, component B and reduced cobalamin. European Journal of Biochemistry. 156(1). 171–177. 58 indexed citations
17.
Diakun, G. P., et al.. (1985). An extended-X-ray-absorption-fine-structure (e.x.a.f.s.) study of coenzyme F430 from Methanobacterium thermoautotrophicum. Biochemical Journal. 232(1). 281–284. 10 indexed citations
18.
Ankel‐Fuchs, Dorothe, et al.. (1984). Functional relationship between protein-bound and free factor F430 in Methanobacterium. Archives of Microbiology. 139(4). 332–337. 37 indexed citations
19.
Pfaltz, Andreas, J. Schreiber, Dorothe Ankel‐Fuchs, et al.. (1984). Zur Kenntnis des Faktors F430 aus methanogenen Bakterien: Struktur des proteinfreien Faktors. Helvetica Chimica Acta. 67(1). 334–351. 73 indexed citations
20.
Pfaltz, Andreas, J. Schreiber, Albert Eschenmoser, et al.. (1984). ChemInform Abstract: FACTOR F430 FROM METHANOGENIC BACTERIA: STRUCTURE OF THE PROTEIN‐FREE FACTOR. Chemischer Informationsdienst. 15(16). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria J. Feio Breakdown of academic impact, for papers by Aaron W. Puri Breakdown of academic impact, for papers by A Böck Breakdown of academic impact, for papers by Karine Bagramyan Breakdown of academic impact, for papers by Stefan Siemann Breakdown of academic impact, for papers by Athanasios Paschos Breakdown of academic impact, for papers by Alexandra Gennaris Breakdown of academic impact, for papers by Jürgen Moser Breakdown of academic impact, for papers by Yu Zeng Breakdown of academic impact, for papers by Endang Purwantini
Rankless by CCL
2026